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cmd44@cam.ac.ukT70N human lysozyme is the only known naturally occurring destabilised
lysozyme variant that has not been detected in amyloid deposits in human
patients. Its study and a comparison of its properties with those of the
amyloidogenic variants of lysozyme is therefore important for under-
standing the determinants of amyloid disease. We report here the X-ray
crystal structure and the solution dynamics of T70N lysozyme, as
monitored by hydrogen/deuterium exchange and NMR relaxation
experiments. The X-ray crystal structure shows that a substantial structural
rearrangement results from the amino acid substitution, involving residues
45–51 and 68–75 in particular, and gives rise to a concomitant separation of
these two loops of up to 6.5 A˚. A marked decrease in the magnitudes of the
generalised order parameter (S2) values of the amide nitrogen atom, for
residues 70–74, shows that the T70N substitution increases the flexibility of
the peptide backbone around the site of mutation. Hydrogen/deuterium
exchange protection factors measured by NMR spectroscopy were
calculated for the T70N variant and the wild-type protein. The protection
factors for many of backbone amide groups in the b-domain of the T70N
variant are decreased relative to those in the wild-type protein, whereas
those in the a-domain display wild-type-like values. In pulse-labelled
hydrogen/deuterium exchange experiments monitored by mass spec-
trometry, transient but locally cooperative unfolding of the b-domain of the
T70N variant and the wild-type protein was observed, but at higher
temperatures than for the amyloidogenic variants I56T and D67H. These
findings reveal that such partial unfolding is an intrinsic property of the
human lysozyme structure, and suggest that the readiness with which it
occurs is a critical feature determining whether or not amyloid deposition
occurs in vivo.
q 2005 Elsevier Ltd. All rights reserved.
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A familial form of non-neuropathic amyloidosis
is associated with mutations in the gene encoding
the antibacterial protein lysozyme.1–3 In this mol-
ecular disease, deposition of pathogenic variant
lysozyme molecules in the form of amyloid fibrils
occurs in internal organs, notably the liver, spleen
and kidneys.1–3 Lysozyme is a 130 residue protein
whose structure is composed of an a-domain
(residues 1–40 and 83–130) and a b-domain
(residues 41–82), between which lies the active sited.
824 Structure and Solution Dynamics of T70N Lysozymecleft.4 There are five known mutations in the human
lysozyme gene that give rise to six variant proteins,
I56T (Thr for Ile at position 56), F57I (Ile for Phe at
position 57), W64R (Arg for Trp at position 64), D67H
(His for Asp at position 67), T70N (Asn for Thr at
position 70) and the double mutant F57I/T70N.1–3,5
The F57I and W64R proteins have been identified
by DNA sequencing (F57I, W64R) and immuno-
histochemistry (W64R) but, unlike the I56T and
D67H variants have not been purified from tissues
or biological fluids from patients carrying these
mutations.2,3 Nevertheless, individuals carrying
these genetic mutations have been found to develop
amyloidosis, implying that the effects of the
mutations are directly responsible for the disease.
Of the naturally occurring mutational variants, only
the T70N variant has not been associated with
amyloid deposits in vivo.2,6 The I56T, W64R and
F57I mutations all affect residues at the interface
between the a and b domains, whereas the D67H
and T70N mutations occur in the long loop of the
b-domain.4 PCR amplification of the lysozyme gene
has indicated that 5–6% of the population in Canada
and the UK carry the T70N lysozyme allele;2,5 a
similar prevalence of the T70N allele has been found
in patients suffering from systemic amyloidosis in
the UK.6 No amyloid deposits of T70N lysozyme,
however, have yet been observed and no
co-deposition of T70N lysozyme was detectable in
a patient affected with immunoglobulin light chain
amyloidosis.2,6
The formation of amyloid fibrils from lysozyme
has been demonstrated to proceed in vitro through a
nucleated mechanism,7,8 a common process in the
formation of amyloid fibrils.9–11 The native states of
the I56T and D67H variants have been found to be
destabilised significantly relative to wild-type
lysozyme and therefore to be able to undergo
transient partial unfolding, under conditions
where the native state of the wild-type protein is
essentially fully populated.8,12 The native states of
these two variants are, therefore, in dynamic
exchange with a low concentration of partially
unfolded species. In these transient species, the
b-domain and the C-helix are unfolded simul-
taneously, whereas the rest of the a-domain largely
maintains its native-like structure. It has been
postulated that the partially unfolded lysozyme
molecules can then undergo an initial self-associ-
ation step through the unfolded b-domain and
C-helix.12,13 Reorganisation of these species, prob-
ably involving the recruitment of more of the
lysozyme sequence into b-sheet structure, and
further association of partially unfolded lysozyme
molecules leads to ordered aggregates, and
eventually to well-defined fibrillar structures.
X-ray fibre diffraction studies show that such
lysozyme fibrils have the cross-b structure that is
characteristic of amyloid fibrils.7,14 Solubilisation of
ex vivo fibrils of the I56T and D67H variants have
shown that the protein molecules are incorporated
into fibrils without proteolysis or modification and
with all the disulfide bonds intact.1,13A critical population of at least partially unfolded
molecules is thought to be a prerequisite for both
the initial nucleation steps, and for growth and
elongation of the lysozyme fibrils. Relatively facile,
transient partial unfolding at 37 8C has been
observed for both the I56T and D67H variants at
pH 8;8,12 however, no detectable population of
partially unfolded species has been detected at
this temperature and pH for the wild-type protein.8,12
The ability to access such species under physiologi-
cally relevant conditions is a property common to
both the I56T and D67H variants and is thought to
be the primary origin of their amyloidogenic
character,8,12 rather than any differences in the
intrinsic properties of the partially unfolded lyso-
zymes or the specific structure of the proteins in
their native states.8,12,15 Indeed, stabilisation of the
native states of the I56T and D67H variants using a
camelid antibody fragment has proved to be highly
effective in preventing both partial unfolding and
fibril formation.7,8
T70N lysozyme has been the subject of initial
characterisation by biophysical and structural
techniques. Stopped-flow fluorescence spec-
troscopy has shown that this variant unfolds three
to four times faster than the wild-type protein, but
refolds from a chemically denatured state with
kinetics similar to those of the wild-type protein.6
Measurements under equilibrium conditions in the
presence of chemical denaturants and studies of
thermal unfolding have demonstrated that T70N is
destabilised significantly relative to the wild-type
protein but to a lesser extent than the amyl-
oidogenic lysozymes.6,8,13 No loss in cooperativity
was detected in the native state of the T70N variant,
and the protein was found to be enzymatically
active and to have near-UV and far-UV CD spectra
similar to those of the wild-type protein.6 We report
here the crystal structure of T70N lysozyme at 2.5 A˚
resolution, and a detailed characterisation of the
native state dynamics by NMR and mass spec-
trometry. We describe the extent of partial unfold-
ing of T70N and wild-type lysozymes at various
temperatures, information that gives new insight
into the structural transitions required for lysozyme
amyloidosis.Results
X-ray crystal structure of T70N lysozyme
T70N human lysozyme was crystallised as
described in the Materials and Methods and the
structure solved at 2.5 A˚ resolution (Brookhaven
Protein Data Bank (PDB) 1W08). The space group
(P212121) was the same as that found for the wild-
type protein (PDB 1JSF, 1LZ1 and 1REX); the
crystallographic properties are listed in Table 1.
The structure shows that the overall fold of the
T70N variant is similar to that of wild-type
lysozyme, although a limited rearrangement of the
protein backbone is clearly evident in local regions
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B. Refinement
No. protein atoms 1043
No. solvent atoms 88
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Resolution (A˚) 2.5–41.89




Bond lengths (A˚) 0.016
Bond angles (deg.) 3.041
Mean B value (A˚2) 23.657
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square deviation (RMSD) of the Ca atoms from the
wild-type structure (PDB 1JSF) is 0.71 A˚. Part of the
long loop of the b-domain (encompassing residues
68–75) and part of the first two strands of the
b-sheet structure along with the adjoining short
loop (residues 45–51) both move significantly from
their positions in the wild-type structure, as shown
in Figure 1, with a maximum deviation of 6.5 A˚ for
the oxygen atom of Pro71. A movement of the
structure in this region was suggested in a recent
study involving molecular dynamic simulations,6
although these loops were predicted to move
towards each other, while in the crystal structure
they are observed to move apart. These two regions
pack against each other in the structure of the wild-
type protein such that Arg50 and Ser51, for
example, are within 4 A˚ of Thr70 (PDB file 1JSF).
Additionally, both regions form hydrogen bonds
with Ser61 and Arg62. These findings show that the
T70N mutation causes structural rearrangements in
the region of residues 68–75, and that these are
communicated directly to residues 45–51, and,
through mutual interactions, with residues Ser61
and Arg62.
A plot of the observed deviation for Ca atoms
against residue number (Figure 2) demonstrates
that, in the crystal structure of T70N lysozyme,
the rearrangements due to the mutation affects
the residues that are observed to be perturbed
also in the structure of the D67H variant (PDB
1LYY); however, the rearrangement resulting
from the T70N mutation encompasses fewer
residues and its magnitude is less pronounced
than that for the D67H mutation. The maximum
deviations for the Ca atoms in T70N lysozyme
relative to the wild-type protein are 4.29 A˚ for
Pro71 and 1.9 A˚ for Gly48; for the D67H variant
the corresponding values are 9.62 A˚ and 7.58 A˚.
Interestingly, the position of the Ca atom of
residue 67 is not perturbed significantly in thestructure of D67H, whereas residue 70 has a
deviation of 7.09 A˚.
Two side-chain hydrogen bonding networks have
been identified that are presumed to stabilise the
b-domain of wild-type human lysozyme.4 These
networks are almost entirely disrupted by the
backbone rearrangements in the D67H variant.13
The analogous rearrangements in the T70N variant
do not disrupt either of the hydrogen bonding
networks significantly, although several individual
hydrogen bonds are not formed in the T70N
variant. For example, in T70N the side-chain of
Asn70 flips out of the wild-type network and forms
a hydrogen bond to the main-chain amide hydro-
gen atom of Gly72 but the rest of this network is
conserved. In the second hydrogen bonding net-
work, Pro71, Arg62 and Asn44 all adopt different
conformations, leading to the loss of associated
hydrogen bonds; however, the core of the network
of interactions is otherwise conserved.
Comparison of the D67H variant with wild-type
lysozyme reveals that the structural perturbations
of the native state are transmitted to the domain
interface with the side-chain of Ile56 adopting an
alternative rotameric state.13 This transmitted con-
formational change is not seen in the structure of
the T70N variant. Instead, the side-chain of Ile56
adopts its wild-type position, whilst the side-chain
of Ile59 adopts an alternative rotamer; this latter
structural change does not occur in either the I56T
or D67H variant, where Ile59 adopts its wild-type
configuration. Overall, therefore, the longer-range
effects of the amino acid substitutions in the three
variants differ in subtle ways, both from the wild-
type protein and each other.
Several other features were identified in the
electron density map of T70N lysozyme. A putative
chloride ion binding site was identified near Asn70,
in a position different from that of the chloride ions
associated with the wild-type protein. The side-chain
of Asn70 was orientated to form an intermolecular
hydrogen bond with Asp102. The polypeptide
backbone (in the long loop of the b-domain) forms
several hydrogen bonds to other adjacent regions of
the polypeptide backbone through ordered water
molecules in the structure of the T70N variant. This
network appears to act to stabilise a section of the
protein structure that would otherwise be exposed
to bulk solvent.
Perturbations of the NMR spectra associated
with the T70N substitution
The 1H and 15N NMR spectra of the T70N were
assigned as described in Materials and Methods,
and the chemical shifts of the backbone amide
groups of T70N compared to those of the wild-type
protein (Figure 3). This comparison confirms that
the largest perturbations are clustered around the
site of mutation, with an approximately equal
distribution of resonances shifted upfield and
downfield. Resonances of several residues involved
in the wild-type hydrogen bonding networks, such
Figure 1. (a) Trace of C, Ca, N atoms from the X-ray structures of the T70N (green, PDB 1W08) and D67H (black, PDB
1LYY) lysozyme variants, overlaid onto the wild-type protein (blue, PDB 1JSF). The Figure was drawn with MOLMOL.38
(b) The site of the T70N mutation in the crystal structure of T70N human lysozyme shown in wall-eye stereo. The side-
chain of Asn70 (central) is shown making hydrogen bonds to Pro71 and intermolecularly with Asp102, which is depicted
in cyan as it originates from a neighbouring lysozyme molecule. The putative chloride ligand is depicted by a magenta
sphere, and water molecules identified in the crystallographic structures are depicted as red spheres. The Figure was
drawn with Pymol (Delano Scientific, San Carlos, CA, USA; http://pymol.sourceforge.net/).
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changes; large chemical shift changes are not,
however, limited solely to these residues, and
almost all of the resonances of residues around
the site of mutation exhibit a significant chemical
shift.
The greatest perturbations in chemical shift occur
for residues 50–52 and 59–79. These regions show
considerable overlap with the deviations in atomic
positions observed in the crystal structure, confirm-
ing that the structural rearrangement in solution is
similar to that in the crystal. Importantly, the
crystallographic evidence (Figure 2) suggests that
not all the residues with perturbed chemical shifts
are displaced significantly in the crystal structure;
however, the chemical shift changes imply that
there are subtle differences in the chemical environ-
ments of the amide groups concerned. Moreover,while there are no significant chemical shift changes
associated with residues in the A and B helices,
there are substantial perturbations for resonances
arising from residues in the C and D helices, and the
C-terminal 310 helix. By contrast, several residues
near the C terminus of the protein exhibit relatively
large deviations in their Ca positions from the wild-
type protein, but minimal differences in chemical
shifts (e.g. residues 120 and 129). It is expected that
deviations in NMR chemical shifts would be
associated with any changes in the solution
structure. Hence, it is probable that at least some
of the movements observed in the crystal structure
near the C terminus of the protein are caused by
minor deformations of the protein structure in the
crystal lattice. In support of this conclusion, this
region of the protein in the crystal makes inter-
molecular contacts with the regions of the structure
Figure 3. Perturbation in chemical shifts ((a) 1HN; (b)
15N) for the T70N variant compared to the native wild-
type lysozyme. Chemical shift changes of greater than
0.1 ppm for 1H and 0.4 ppm for 15N are considered
significant, and these boundaries are marked by broken
red lines.
Figure 2. A comparison of the crystallographic Ca atom
deviations for T70N (green, PDB 1W08) and D67H (black,
PDB 1LYY) variants, from their positions in the wild-type
protein (PDB 1JSF).
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T70N mutation.
In contrast to the many changes in chemicals
shifts associated with the T70N mutation, the NMR
spectra of the I56T variant display few significant
chemical shift changes relative to the wild-type
protein, with only four residues having resonances
whose chemical shifts differ by greater than
0.1 ppm from the wild-type values.15 This obser-
vation is consistent with the very minor structural
alterations in the crystal structure (PDB 1LOZ)
found to accompany this mutation. All of these
alterations occur spatially close to the site of
mutation at the domain interface. Unlike the
situation with the I56T variant, the D67H variant
displays large chemical shift changes throughout
much of the b-domain and interface region, with the
greatest perturbations occurring for residues 48–52
and 60–82.15 It is noteworthy that the resonances
involved are approximately the same as those that
are perturbed in the T70N variant.Thermal denaturation of the lysozyme variants
followed by CD spectroscopy
The stability of the I56T, T70N and wild-type
proteins was studied by thermal unfolding, mon-
itored by near-UV circular dichroism (CD). The
unfolding transition for the T70N variant was
observed to be 4.5(G1) deg. C lower than that of
the wild-type protein (Figure 4), with the I56T
variant observed to unfold 10.5(G1) deg. C lower
than the wild-type. These results are in good
agreement with those of previous studies,6,8,13 and
demonstrate that T70N lysozyme is significantly
destabilised (by nearly 5 deg. C) compared to the
wild-type protein, but to a much lesser extent than
the I56T and D67H variants, which both have
transition temperatures approximately 10 deg. C
lower than the wild-type protein.8,13Figure 4. Thermal unfolding of wild-type (blue), I56T
(red), and T70N lysozyme (green) monitored by CD at
270 nm, displayed as the fraction of each protein that is
unfolded, calculated on the basis of a two-state model.
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hydrogen exchange
The hydrogen/deuterium exchange (H/D) prop-
erties of T70N lysozyme were investigated initially
using a pulse-labelling experiment monitored by
mass spectrometry designed to detect any transient
cooperative unfolding events.12 The fully deuter-
ated protein was incubated at pH 8.0 for various
lengths of time, then exchange was quenched at low
pH and low temperature, and the sample analysed
immediately. The premise of this experiment is that,
under appropriate conditions, the labile hydrogen
atoms in a region of a protein molecule that unfolds
cooperatively, even once during the labelling pulse,
will be exchanged simultaneously and irreversibly
at all solvent-exposed sites; this experiment therefore
allows detection of partially unfolded intermediates
even when they are present at only very low
concentrations. The kinetics of hydrogen exchange
are highly dependent upon solution conditions, and
in order to identify unambiguously any differences
between the variants and the wild-type protein,
aliquots of two different proteins were subjected to
exchange in the same solution. In order to separate
the species in the mass spectrometer, one of the two
proteins was uniformly labelled with the stable 15N
isotope. Thus, a series of experiments was carried
out at 37 8C with 15N-labelled I56T lysozyme and
unlabelled T70N lysozyme (Figure 5(a)). A second
series of experiments was conducted at 47 8C with
unlabelled T70N lysozyme and 15N-labelled wild-
type protein (Figure 5(b)). A third series was
conducted at 57 8C with the wild-type protein
alone (Figure 5(c)). A clear bimodal distribution of
masses, indicative of a locally cooperative partial
unfolding process, was observed for peaks corre-
sponding to the I56T variant at 37 8C; this behaviour
is consistent with previous results, which demon-
strate that partial unfolding of the b-domain and
C helix occurs under these conditions.8,12 In
contrast, only a single set of peaks was observed
for the T70N variant at 37 8C. These peaks
decreased slowly in mass as a function of time in
the labelling phase, illustrating that hydrogen
exchange occurs via local fluctuations in structure
that expose few amide groups to the solvent at any
one time; rather than via the cooperative partial
unfolding event that was detected for the I56T
variant.
The hydrogen exchange behaviour of the T70N
variant and 15N-labelled wild-type lysozyme at
47 8C (Figure 5(b)) shows a bimodal distribution of
peaks for the T70N variant, clearly indicating that
partial unfolding occurs at this temperature.
A single set of peaks is, however, still observed for
the wild-type protein, showing that no cooperative
partial unfolding is detectable for the wild-type
protein at 47 8C under the conditions used here.
These results prove that the T70N variant populates
significantly a transiently, partially unfolded state
under conditions where the wild-type does not.
This observation further suggests that the popu-lation of transiently, partially unfolded molecules
for the T70N variant at 37 8C, is indeed too low to be
detected by the H/D experiments carried out here,
but it will be higher for the T70N variant than for
the wild-type protein; although significantly lower
than for the amyloidogenic variants.
Increasing the temperature to 57 8C, however,
results in a clear bimodal distribution of peaks for
the wild-type protein (Figure 5(c)); this result shows
that it too can undergo cooperative partial unfold-
ing at this higher temperature. Moreover, the mass
differences suggest that the nature of the inter-
mediate species being detected under the different
conditions for the different proteins could be
essentially the same. These observations, taken
together, suggest that the ability to populate a
partially unfolded state is an intrinsic property of
human lysozyme rather than being a specific
property of the amyloidogenic variants. Never-
theless, the mutations affect the dynamic equili-
brium between the native and partially unfolded
states, with the result that the latter are present at a
significantly higher population in the amyl-
oidogenic proteins, such that under physiological
conditions they can dominate the aggregation
behaviour that leads to the formation of amyloid
fibrils. Moreover, the equilibrium between the
native and partially unfolded states of the T70N
variant can be seen to lie between that found for the
amyloidogenic variants and for the wild-type
protein.
The rates of H/D of individual labile amide
hydrogen atoms for the T70N and wild-type protein
were then determined at 37 8C and pD 5 using NMR
spectroscopy; from these rates, exchange protection
factors were calculated as defined by the increase in
protection over the rates for the same amide
hydrogen atoms in an unstructured (random coil)
state.17 High protection factors were found in both
proteins for the amide hydrogen atoms in regions
that correspond to elements of secondary structure
in the native state (Figure 6(a)). Amides in the A, B,
and C helices, and in the core of the b-domain, show
the greatest protection against exchange in both
T70N and wild-type lysozymes. Amide groups of
residues in the A and B helices in T70N have
protection factors similar to those found in the same
regions of the wild-type protein, but there are
significant differences for amide groups in the core
of the b-domain. All of the residues with amide
hydrogen atoms showing a greater then tenfold
increase in exchange rates as a consequence of the
T70N mutation are located in the region of residues
39–84 (Figure 6(b)), which corresponds almost
exactly to the b-domain. Interestingly, the greatest
differences between wild-type lysozyme and the
amyloidogenic variants are found in this region.
This observation demonstrates clearly that, while
the structural perturbations of the T70N variant
observed in the crystal structure affect only residues
spatially close to the site of mutation, the dynamic
behaviour detected by hydrogen exchange is
significantly altered for amide groups located in
Figure 5. (a) H/D exchange of the T70N (green) and
I56T (red/yellow) lysozyme variants monitored by
electrospray mass spectrometry at 37 8C. The I56T variant
displays a clear bimodal distribution of peaks indicative
of locally cooperative partial unfolding. The T70N variant
shows a single peak decreasing in mass over time,
indicative of exchange through uncorrelated local fluctu-
ations (see the text). (b) H/D exchange of the T70N
variant and wild-type lysozyme monitored by electro-
spray mass spectrometry at 47 8C. The bimodal distri-
bution of peaks indicative of locally cooperative partial
unfolding is clearly displayed for the T70N variant,
whereas a single peak is observed for wild-type
lysozyme, indicative of exchange occurring via local
fluctuations of the native state. (c) H/D exchange of
wild-type lysozyme monitored by electrospray mass
spectrometry at 57 8C. The bimodal distribution of
peaks indicative of the locally cooperative partial
unfolding step is clearly evident at this temperature.
Figure 6. (a) Protection factors for the amide hydrogen
atoms in the T70N variant, calculated from the rates of
hydrogen exchange monitored by NMR. Residues for
which the hydrogen exchange rates were too fast to be
measured reliably are left blank. (b) Ratios of amide
protection factors for the wild-type lysozyme compared
to those for the T70N variant. The broken line represents
the value for which amide groups of the wild-type protein
have protection factors ten times those of the T70N
variant. A ratio of 1.0 represents an equal degree of
protection in both proteins.
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Figure 7. 15N NMR relaxation data for backbone amide
groups of T70N lysozyme. (a) 15N spin-lattice relaxation
830 Structure and Solution Dynamics of T70N Lysozymemuch of the b-domain and C helix. Thus, the
dynamic behaviour is perturbed in some regions of
the protein where the observed structural changes
are very small. It is not clear, however, whether this
increase in susceptibility to exchange caused by the
mutation results from the great sensitivity of
fluctuations in the protein backbone to small
changes in structure, or the result of larger
correlated changes in dynamic behaviour.Fast timescale dynamics from NMR relaxation
measurements
To investigate the dynamic properties of the
T70N variant on the timescale of nanoseconds to
picoseconds, a series of 15N NMR relaxation
experiments were recorded (T1, T2 and {
1H–15N}-
nuclear Overhauser effect (NOE), Figure 7(a)–(d)).
Relaxation data were obtained for 122 out of the 130
residues in the protein.
The most significant differences in the relaxation
behaviour between the T70N variant and the wild-
type protein are increases in the T1 and T2 relaxation
times for residues 69–74, reflecting an increase in
their fast timescale (picoseconds) dynamics (G.L.
et al., unpublished results).17 Asn70, the residue
introduced by the genetic mutation, was found to
have the highest T1 and T2 values, 530(G28) ms and
236(G6) ms, respectively, compared to the mean
values of 402 ms G3.8% and 154 ms G1.8% for the
T1 and T2 relaxation times. A decrease in the NOE
effect was observed for the same residues, with
Asn70 exhibiting the lowest NOE value of 0.43,
compared to an average of 0.74 for the T70N
variant. In contrast, no decrease in the NOE effect
is observed for residues 70–74 in the wild-type
protein relative to other residues (G.L. et al.,
unpublished results).17 Ser51 is another interesting
residue, as it has a slightly decreased NOE effect
(0.66) in the T70N variant compared to wild-type
lysozyme (0.80). Interestingly, a large reduction in
NOE values is found in the D67H variant for the
adjacent residue Arg50 (0.40); however, Arg50 (0.78)
in the T70N variant is actually higher than that
found in the wild-type protein (0.71). These
residues all reside on the two regions (residues
43–53 and 67–75) perturbed in the crystal structures
of the D67H and T70N variants, and the differences
in the NOE effects presumably result from changes
in dynamic behaviour associated with the structural
reorganisations.
The relaxation data were analysed according to a
model-free formulism18–20 using the program Mod-
elfree (version 4.15).21 Among other parameters,
this analysis generates order parameters (S2),
which reflect the local dynamics on a timescale of
! ca 200 ps. The data were fit to a model oftime constants (T1). (b)
15N spin-spin relaxation time
constants (T2). (c) {
1H}-15N heteronuclear NOE effects.
(d) Generalised order parameters (S2).
Structure and Solution Dynamics of T70N Lysozyme 831isotropic rotation with a rotational correlation time
of 4.7(G0.1) ns. These results show that, like the
wild-type protein, T70N lysozyme is highly struc-
tured, with high order parameters (above 0.8)
throughout most of the protein backbone
(Figure 7(d)), and that the overall tumbling rate is
essentially the same as for the wild-type protein
(G.L. et al., unpublished results).17 Large decreases
in order parameters relative to the wild-type
protein are seen, however, for residues 69–74, as
expected from the differences in relaxation times
discussed above. Indeed, the S2 values reach a
minimum of 0.57 for Asn70, demonstrating clearly
that the reorganisation in the vicinity of the
mutation site results in greater flexibility of the
peptide backbone. A similar decrease in order
parameters has been observed for the D67H variant;
although the decrease was significantly greater in
magnitude (G.L. et al., unpublished results).
Aggregation kinetics
The rates at which I56T, T70N and wild-type
lysozymes aggregate were measured by right-angle
light-scattering, under specific conditions shown
previously to be conducive to the formation of
amyloid fibrils containing the full-length protein
molecules (Figure 8).7 The kinetic profiles in each
case show the existence of a lag phase followed by
rapid growth, behaviour typical of a nucleated
process and observed previously for the D67H
variant and many other similar amyloidogenic
systems.7–11 Although the kinetics varied somewhat
from one experiment to the next, a clear trend in the
length of the lag phase and rate of aggregation
(I56TOT70NOwild-type) emerged. Under the con-
ditions used, the midpoints of the aggregation
reaction are approximately: I56T, 210(G40) min; T70N,
750(G175) min; and wild-type, 1500(G250) min. There-
fore, the rate of aggregation follows both theFigure 8. Aggregation of lysozyme monitored by right-
angle light-scattering. The data represent the average of
three experiments. Data for the I56T variant are shown in
red, for T70N in green, and for the wild-type protein in
blue.decrease in the native state stability of the variants,
and the increase in the population of the partially
unfolded states. This result shows that the T70N
variant has a propensity to aggregate that is
intermediate between the I56T/D67H variants and
the wild-type protein.Discussion
Comparison of the structures of the T70N variant
and wild-type lysozymes
The overall structure of T70N lysozyme is very
similar to that of the wild-type protein, except for
some rearrangements in the b-domain in the
vicinity of the mutation. These rearrangements are
similar to those observed for the D67H variant;
however, in contrast to the D67H variant, the side-
chains in the T70N variant are still able to form the
core of the two side-chain hydrogen bonding
networks found in the b-domain of the wild-type
protein. The structural rearrangements in the
vicinity of the T70N substitution are, therefore, not
transmitted through the polypeptide chain to
the interface between the a and b domains, in the
manner seen for the D67H variant. The effects of the
mutation on the native structure are restricted
largely to residues that are spatially close in
structure to Asn70. Long-range effects appear to
be relatively minor; for example, the side-chain of
Ile59 adopts an alternative rotamer in the T70N
variant. The rearrangement in the native state of
this variant does, however, provide an explanation
for the measurable decrease in stability, as several
stabilising hydrogen bonds present in the wild-type
protein are not formed in the T70N variant.
Moreover, there are some slight differences in the
packing of the side-chains of a number of residues
in the interior of the protein, such as the side-chain
of Ile59, which adopts an alternative rotameric state.
Interestingly, the extent of the structural rearrange-
ment in T70N is intermediate between that
observed in the D67H variant and wild-type
lysozyme, a result consistent with the intermediate
thermostability of its native state.
The crystal structure of the I56T variant is
essentially the same as that of the wild-type protein,
strongly suggesting that a rearrangement of the
native fold is not required for either the transient
unfolding event or amyloid fibril formation;13
however, the ability of the I56T and D67H variants
to transiently populate a partially unfolded state
can be rationalised as being the effect of the loss of
interactions in the native state, either directly from
the mutations or as a consequence of the associated
conformational changes. Studies of a variety of
proteins using site-directed mutagenesis have
shown that amino acid substitutions affecting
certain key residues can alter the rates of protein
unfolding and refolding substantially, and thus
perturb the equilibrium position between two
states.22,23 Interestingly, examination of all the
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zyme involve residues that form important long-
range native interactions in the wild-type protein.4
Although the structures of the F57I and W64R
variants have not been reported, it is clear that the
side-chains introduced by the mutations have
sufficiently different properties from those present
in the wild-type protein that at least some of the
wild-type interactions will be disrupted. Hence, the
I56T, F57I and W64R mutations are known (I56T) or
expected (F57I, W64R) to disrupt long-range
hydrophobic interactions that bridge the a and b
domain interface. The D67H mutation, on the other
hand, perturbs the side-chain hydrogen bonding
networks associated with the b-domain, and the
resulting perturbations are transmitted through the
protein to the region of the domain interface.
In both the amyloidogenic variants (I56T/D67H)
of lysozyme studied in detail so far, the b-domain
and domain interface region are perturbed sub-
stantially by the mutations. In contrast, the T70N
mutation does not appear to perturb significantly
the domain interface region or the hydrogen
bonding networks in the b-domain. The greater
disruption of stabilising interactions in the
b-domain and the interface region, therefore,
provides an explanation of the greater tendency of
the I56T and D67H variants to populate a partially
unfolded state, relative to the T70N variant and the
wild-type protein. It should be noted, however, that
the destabilising T70N mutation is located in the
b-domain, i.e. in the region of the protein that
unfolds in a locally cooperative manner. This
observation raises the question of whether the
position of mutation is intrinsically important for
promoting amyloidogenicity. These results suggest
that the propensity of a variant for partial unfolding
is linked to the reduction in the stability of the
b-domain; however, it is unclear whether disrup-
tion of the domain interface region is a requirement
for facile unfolding, or what the affect would be of a
mutation that resulted in a comparable reduction in
stability of the a-domain.
Implications for amyloid disease
The formation of amyloid fibrils from lysozyme is
thought to proceed through partial unfolding of the
protein, localised primarily in the b-domain and the
interfacial region of the a-domain; this process
enables self-association to occur by contact with
another partially unfolded lysozyme molecule
through the mutually unfolded regions of the
polypeptide chain. The T70N mutation destabilises
the native fold, but no transient and cooperative
partial unfolding transition was detected for the
T70N variant at 37 8C. At higher temperatures, the
T70N variant (47 8C) and wild-type protein (57 8C)
both undergo partial unfolding in a locally
cooperative manner that is essentially identical
with that seen at lower temperature for the
amyloidogenic I56T and D67H variants. These
observations demonstrate that this unfolding beha-viour is an intrinsic property of the lysozyme fold,
with an increase in the rate of partial unfolding
linked to a decrease in native state stability. This
suggests that under physiological conditions the
amyloidogenic variants have a higher population of
partially unfolded species than the T70N variant,
which in turn has a higher population than the
wild-type protein. Moreover, the I56T and wild-
type lysozymes have been found to form partially
unfolded species at low pH.14 These partially
unfolded forms are characterised by a loss of
tertiary structure preceding the loss of secondary
structure, and are stable at equilibrium rather than
being a transient species; however, a lower tem-
perature is needed to form such a state for the I56T
variant than for the wild-type protein. Taken
together, these findings indicate that mutations
that destabilise the native state of lysozyme reduce
the severity of the conditions required to populate a
partially unfolded state, rather than generate new
states that are inaccessible to the wild-type protein.
Under physiological conditions, the T70N variant
and even the wild-type protein are likely to
populate partially unfolded states analogous to
those identified for the amyloidogenic variants, but
at much lower levels.
In order for such an intermediate state of this
nature to be detected in hydrogen exchange mass
spectrometry experiments, of the type described
here, the rate of unfolding to form the intermediate
must be fast enough relative to the rate of hydrogen
exchange occurring through minor fluctuations in
the native state, to allow hydrogen exchange to
occur through the cooperative unfolding transition.
Under such conditions, hydrogen exchange taking
place as a result of the cooperative unfolding
transition can be detected, as any exchangeable
hydrogen atoms will be labelled irreversibly by
their first exchange-competent opening transition.
If, however, the rate of the cooperative unfolding
process is slow compared to the rate of local
fluctuations, the observed rate of hydrogen
exchange will be dominated by the rate of
exchange arising from the minor fluctuations in
the native state. Therefore, any very slow partial
unfolding process, even if they were occurring,
would be obscured and undetectable in experi-
ments of this type.
In contrast to the situation at pH 8, the intrinsic
rate of hydrogen exchange at pH 5 is much slower
than the rate of protein refolding, with hydrogen
exchange occurring through an EX2 mechanism.12
Hence, the protection factors for any residues
exchanging solely through partial unfolding will
be equal to the equilibrium constant linking the
partially unfolded and native states.12 Residues 53,
54, 55, 58, 59, 61 and 65 in the core of the b-domain
of human lysozyme are highly protected in the
wild-type protein, but are known to exchange via
the locally cooperative partial unfolding process
described above in the I56T and D67H variants.8,12
The protection factors for these residues were
averaged to give an equilibrium constant for the
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variants. In the case of the T70N variant, however,
these residues are not exchanging solely through
partial unfolding of the protein. Thus the observed
rate of hydrogen exchange gives only an equili-
brium constant corresponding to the maximum
possible population of the intermediate. (The
maximum rate of hydrogen exchange arising
through cooperative unfolding is equal to the
observed rate of hydrogen exchange.) It should be
noted, however, that the actual population of the
intermediate for the T70N variant is lower than the
maximum possible population, with the difference
being dependent upon the relative contributions of
local and partial unfolding to hydrogen exchange.
The D67H and I56T variants have a calculated
equilibrium constant of 4370 and 4460, respectively,
indicating that approximately one molecule in 4500
molecules is in a partially unfolded state at 37 8C.
The average of the protection factors for the T70N
variant is, however, ca 1.8!105 at 37 8C, a value that
is approximately 40 times greater than that for the
I56T and D67H variants. These findings indicate
that the T70N variant has a population of the
partially unfolded state that is at least 40 times less
than that of the amyloidogenic variants at physio-
logical temperature. The probability of a partially
unfolded aggregation-prone molecule encountering
another such molecule will therefore be decreased
by a factor of at least 1600.
The present study shows, therefore, that the rates
of aggregation of the variant proteins in vitro
correlate with the decrease in the native state
stabilities caused by the mutations, with that of
the T70N variant being intermediate between the
I56T variant and the wild-type lysozyme. The
decrease in the native state stability of the variant
proteins results in an increase in the population of
the aggregation–prone partially unfolded state.
Previous studies of the kinetics of lysozyme
amyloid fibril formation in vitro, suggests that this
process takes place through a nucleation-elongation
mechanism.7,8 In such a process, the nucleation step
is thought to involve self-association of protein
molecules through unfolded regions of the poly-
peptide chain, while fibril elongation depends on
the condensation of partially unfolded molecules
onto the fibrillar species.13 If this mechanism holds
in vivo, a reduction in the concentration of partially
unfolded molecules would both prolong the
nucleation phase and retard fibril elongation,
thereby inhibiting the aggregation process and
decreasing the risk of amyloid disease.
Despite the destabilisation of its native state as a
result of the mutation, the T70N variant of human
lysozyme has not been identified in any amyloid
deposits in vivo, suggesting that under normal
conditions the population of partially unfolded
molecules is below the threshold level required for
the accumulation of protein aggregates in tissue; the
T70N variant does, however, partially unfold
significantly more readily than the wild-type
protein, suggesting that it is more susceptible tofibrillar aggregation. In the case of transthyretin
(TTR), a protein involved in another hereditary
amyloidosis, destabilising mutations cause early-
onset amyloid disease, but wild-type TTR also
aggregates in vivo to cause late-onset amyloidosis.
Indeed, relatively minor amyloid deposits contain-
ing TTR are common in people over the age of
80 years.24,25 It is therefore possible to envisage that
T70N lysozyme amyloidosis could occur as a late-
onset disease as result of physiological stress, or
that co-deposition of T70N lysozyme in amyloid
deposits could increase the severity of amyloidoses,
primarily caused by the aggregation of another
protein. Although deposits containing T70N (or
indeed wild-type) lysozyme have not been
reported, it will be interesting to examine in greater
detail whether or not such a situation could occur
under at least some circumstances.Materials and Methods
Preparation of T70N mutant
The wild-type human lysozyme gene was inserted into
a pPIC9 expression vector (Invitrogen). The T70N
mutation was introduced using LDA-PCR,26 with phos-
phorylated primers 5 0-ACGGTAAGAACCCAGGCG
CCGTTA-3 0, and 5 0-GCATTCTGACATCCTCTTGAT
TAGA-3 0, and its presence was confirmed by DNA
sequencing. The pPIC9 plasmid containing the T70N
lysozyme gene was linearised by digestion with StuI.
Transformation into Pichia pastoris GS115 was performed
using a Biorad micropulser electroporation apparatus.
The cells were then plated on regeneration dextrose (RD)
agar plates (Invitrogen) to produce single-clone colonies,
which were screened for lysozyme activity with a
hydrolase activity assay using Micrococcus lysodeikticus
cells as the substrate.27
Typical protein expression
Buffered minimal glycerol (BMG) precultures (3 !
6 ml) in 50 ml Falcon tubes were inoculated with
P. pastoris cells containing the T70N lysozyme gene. To
increase aeration of the precultures, the tubes were tilted
by 458 and shaken in an orbital incubator at 230 rpm for
36 h at 30 8C. Aliquots (2 ml) of the preculture cell
suspension were used to inoculate 200 ml of BMG
medium in 2 l Erlenmeyer flasks. The cultures were
incubated at 30 8C and 230 rpm for 28 h then centrifuged
in sterile centrifuge bottles at 1500g for 5 min. The
supernatant was decanted off and the cells resuspended
in 400 ml of buffered minimal methanol (BMM) to induce
protein expression. The BMM suspensions were incu-
bated at 30 8C and 230 rpm. Every 24 h, 2 ml of methanol
was added to the culture. After 72 h, the methanol-
containing cultures were centrifuged at 1500g at 4 8C for
5 min. The supernatant was kept at 4 8C, filtered at
0.45 mm pore size, then purified using a cation-exchange
(Poros 20 HS) column (Applied Biosystems, UK) on a
Biocad 700E system (Applied Biosystems, UK). T70N
lysozyme was eluted from the column by a linear
gradient of NaCl solution (0–1 M). Fractions were
analysed by SDS-PAGE and those containing only
lysozyme were combined, dialysed against water and
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mined by measuring the absorbance at 280 nm, using E1%280
for 1 cm path-length Z25.5.13 The protein mass was
analysed by electrospray ionisation time-of-flight
(ESI-TOF) mass spectrometry (T70N, calc. 14,706 Da,
obs. 14,707(G1) Da; wild-type, calc. 14,693 Da, obs.
14,693(G1) Da).
15N-labelled protein was prepared either as described28
(I56T, wild-type) or expressed in P. pastoris (T70N, wild-
type) with 200 ml of Fm22 glycerol medium (42.87 g of
KH2PO4, 5 g of (NH4)SO4, 0.5 g of CaSO4, 14.28 g of
K2SO4, 6 g of MgSO4, 1 ml of PTM1 salt solution, 800 mg
of biotin, 100 ml of glycerol, adjusted to 1 l with water,
and to pH 6 with KOH) to build cell mass, and 400 ml
of Fm22 methanol medium (42.87 g of KH2PO4, 5 g of
(15NH4)SO4, 0.5 g of CaSO4, 14.28 g of K2SO4, 6 g of
MgSO4, 1 ml of PTM1 salt solution, 800 mg of biotin, 50 ml
of methanol, adjusted to 1 l with water, and to pH 6 with
KOH) to induce protein expression. The resulting
15N-labelled protein was purified as described above for
the unlabelled protein.X-ray crystallography
Crystals were grown using the hanging-drop, vapour-
diffusion method at 293 K. A sample (2 ml) of lysozyme
solution (10 mg/ml of protein, 10 mM Hepes (pH 7.5),
0.4 M LiCl) was mixed in a ratio of 1:1 (v/v) with the
reservoir solution (20 mM sodium acetate (pH 4.5), 2.5 M
NaCl). Small, predominately rod-shaped crystals grew
over a period of several weeks, which were unsuitable for
structure determination; however, a single, larger crystal
was formed. This crystal was flash-frozen in a nitrogen
stream using a cryo-protectant of 25% (v/v) glycerol in
reservoir solution. Diffraction data were collected with 18
oscillations, at 100 K, using an MSC R-axis II image plate
and Rigaku RU200 rotating anode X-ray generator and an
osmic mirror (lZ1.5418 A˚). Diffraction intensities were
integrated out to 2.5 A˚ with the computer program Denzo
and scaled with Scalepack (Table 1).29 The crystal space
group was P212121 with unit cell dimensions aZ31.117 A˚,
bZ56.178 A˚, cZ62.488 A˚. Molecular replacement was
carried out with AMoRe,30 using wild-type human
lysozyme (PDB 1JSF) with residues 68–73 deleted as the
search model. The structure was refined initially via
repeated cycles of simulated annealing using CNS31 and
manual rebuilding (QUANTA, Accelrys Inc. San Diego,
USA), until the loop region in the vicinity of the mutation
had settled into a consistent position. Subsequently, the
structure was refined with restrained refinement using
Refmac,32 and solvent atoms were added. Refinement and
manual rebuilding were continued until the atom
positions were consistent and Rfree had stabilised (0.27).
The quality of the stereochemistry was evaluated using
PROCHECK,33 and the structure was solved indepen-
dently using RAPPER to confirm there were no significant
defects.34† http://www.cgl.ucsf.edu/home/sparky/NMR spectroscopy
A 15N-labelled T70N sample was prepared in a Shigemi
tube by dissolving 3.7 mg of 15N-labelled protein in 400 ml
of 90% H2O, 10%
2H2O and adjusted to pH 5.0.
Assignment of 15N heteronuclear single quantum
coherence (HSQC) spectra of T70N lysozyme at 37 8C
was conducted initially using the assignments for the
wild-type protein (G.L. et al., unpublished results).35
Unassigned residues were then assigned using 3D HSQC-total correlated spectroscopy (TOCSY) and 3D HSQC-
NOESY spectra. 1H and 15N chemical shifts were
determined from an HSQC spectrum recorded at 37 8C
with 32 transients, 1024 complex points in t2 and 256 in t1,
and sweep widths of 8389 Hz in F2, 2554 Hz in F1 on a
Bruker Avance 700 MHz NMR spectrometer equipped
with a TXI probe.
15N T1, T2 and NOE relaxation data were recorded at
37 8C on a Bruker Avance 500 MHz NMR spectrometer.
The NOE and NONOE experiments were recorded in an
interleaved fashion with a relaxation delay of 5 s, 56
transients, 1024 complex points in t2, and 124 in t1 and
with sweep widths of 7508 Hz in F2, 1824 Hz in F1. The T1
and T2 experiments were recorded with 16 transients (T1)
and 32 transients (T2), 1024 complex points in t2 and 128 in
t1, and sweep widths of 7042 Hz in F2, 3846 Hz in F1. (T1
delays in ms, 15.96, 1596, 31.93, 798.2, 47.89, 598.7, 79.82,
478.94, 119.74, 359.2, 199.6, and 279.38); (T2 delays in ms,
7, 14, 28, 42, 56, 70, 84, 140, 119, 161, 203, 245, and 294).
All spectra were processed with NMRPipe,36 and
viewed with Sparky† or NMRView.37 Relaxation and
exchange rates were fit to a two-parameter, single-
exponential decay with nmrView. Analysis of relaxation
parameters was carried out with the extended model-free
formulism18–20 in Modelfree,21 using a chemical shift
anisotropy for an amide 15N nucleus of –160 ppm and a
N–HN bond length of 1.02 A˚. The data were fit using an
isotropic model with a rotational correlation time of
4.7 ns.
Real time H/D measurements
Lysozyme samples (T70N/WT) were dissolved in
550 ml of 20 mM D-4 acetic acid in 2H2O pD 5. The sample
was immediately placed in the Bruker Avance 700 MHz
NMR spectrometer pre-tuned and shimmed with an
equivalent sample. A series of HSQC spectra were
recorded with eight transients, 1084 complex points in
t2, 96 in t1 and sweep widths of 7042 Hz in F2 and 2199 Hz
in F1. Hydrogen exchange rates were measured from the
reduction of peak volume over time. Protection factors
were calculated from the ratio of experimental rates to the
predicted rates for a random coil model based on the
primary structure.16
Mass spectrometry
15N-labelled I56T, unlabelled T70N, unlabelled wild-
type and 15N-labelled wild-type lysozymes were deuter-
ated at exchangeable sites by unfolding in guanidinium
chloride (predeuterated by three cycles of dissolution in
2H2O followed by lyophilisation) in
2H2O. The proteins
were refolded via dilution in 2H2O and subsequently
concentrated. Cycles of dilution and concentration in
2H2O were repeated until no guanidinium ion contami-
nation was observed in mass spectra of lysozyme. For
comparative experiments, solutions with an equal con-
centration of T70N and 15N-labelled wild-type, or T70N
and 15N-labelled I56T lysozyme, were prepared before the
initiation of hydrogen exchange. The final concentration
of protein in each experiment was 8 mM for each
constituent. Samples were prepared by manual mixing
of 20 ml of protein solution with 300 ml of pulse-labelling
buffer (100 mM ammonia/formic acid (pH 8), in H2O) at
37 8C for various lengths of time (0.5 s–1 h) followed by
quenching with 140 ml of 1 M acetic acid. After quenching,
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immediately by mass spectrometry. A fully exchanged
sample was prepared by incubating the protein in the
pulse-labelling buffer for 15 min at 80 8C prior to
quenching. No adjustment has been made to the total
number of exchanged hydrogen atoms for the 6%
deuterium present in the pulse solutions. Mass spectra
of pulse-labelled samples were recorded using a Micro-
mass LC-ToF spectrometer (Micromass) with cone
voltage of 80 V as described.12 For each experiment, 2 ml
of protein solution was used and the mass spectra shown
(Figure 5) represent the convolution ofC7,C8,C9 charge
states with minimal smoothing and converted to a mass
scale. Rates of partial unfolding were calculated from
variations in peak intensity over time.
Circular dichroism
T70N or wild-type human lysozyme was dissolved in
10 mM sodium acetate (pH 5.0) and filtered at 0.22 mm
pore size. The protein was diluted to a final concentration
of 0.2 mg/ml and overlaid with mineral oil. Spectra were
recorded at 270 nm with a 10 mm path-length cuvette.
Thermal unfolding was monitored between 20 8C and
97 8C with a temperature increase of 0.5 deg. C/min.
Ellipticity values were normalised to the fraction of
unfolded molecules (Fu) using FuZ ðqKqNÞ=ðqUKqNÞ,
where q is observed ellipticity, qN is native ellipticity
and qU is unfolded ellipticity. qN and qU were obtained by
extrapolation from the pre and post-transition baselines at
the relevant temperature. Curve fitting was carried out
with Kaleidagraph (v3.51, Synergy software, Reading PA)
.
Aggregation kinetics
Stock solutions of the proteins were filtered at 0.22 mm
pore size and diluted to a final concentration of 0.1 mg/
ml of protein in 0.1 M tri-sodium citrate buffer (pH 5.5)
containing 3 M urea. Samples were incubated at 48 8C,
with stirring, in a Cary Eclipse spectrofluorimeter and
shaken every 20 min to ensure dispersion of protein
aggregates. Protein aggregation was monitored through
changes in the fluorescence emission at 500 nm; the
excitation wavelength was 500 nm, and excitation and
emission slit-widths were 5 nm.
Protein Data Bank accession numbers
The crystallographic coordinates and structure factors
have been deposited in the Protein Data Bank (PDB file
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